11th Oct 2013 16:06
LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that a group of its senior executives, including Chief Executive Officer Andrew Witty and Chief Financial Officer Simon Dingemans, acquired shares at a price of 1546.50 pence and USD50.22 per American Depositary Share last Thursday through a dividend re-investment program.
Each also received the same number of matching shares.
Witty 1,417 shares
Dingemans 508 shares
Simon Bicknell 213 shares
Roger Connor 58 shares
David Redfern 335 shares
Claire Thomas 215 shares
Phil Thomson 11 shares
Patrick Vallance 713 shares
Emma Walmsley 284 shares
Moncef Slaoui 647 ADS's
Deidre Connelly 115 ADS's
William Louv 95 ADS's
Daniel Troy 306 ADS's
Shares in the pharmaceutical company closed up 9.00 pence at 1,554.50 pence Friday.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Glaxosmithkline